eccogene glp-1 New receptor agonists identified at Oral GLP-1-Based Therapeutics in the

The 2026 broader peptide-therapy reviews (PMID 41966639) place this compound class in the wider research-context of unapproved compounds under active investigation

In the past 12 months, Amgen's stock has risen by only 8%, as investors don't appear to be overly enthusiastic about its prospects, despite its potential in the GLP-1 drug market

excessive urinary oxalate excretion and calcium oxalate saturation was decreased at the end of the trial (Siener 2011)

This is necessary for proper absorption in the stomach

CD24 CD24 is a small, heavily glycosylated surface protein involved in cell adhesion and signaling

Evidence for eosinophil and IL-17 mediated inflammation in allergic rhinitis